Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT
Background Despite a growing number of prescriptions for antidepressants (over 70 million
in 2018), there is uncertainty about when people with depression might benefit from …
in 2018), there is uncertainty about when people with depression might benefit from …
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo …
Background Depressive symptoms are usually managed within primary care and
antidepressant medication constitutes the first-line treatment. It remains unclear at present …
antidepressant medication constitutes the first-line treatment. It remains unclear at present …
What predicts response to sertraline for people with depression in primary care? a secondary data analysis of moderators in the PANDA trial
Purpose Antidepressants are a first-line treatment for depression, yet many patients do not
respond. There is a need to understand which patients have greater treatment response but …
respond. There is a need to understand which patients have greater treatment response but …
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled …
Background Depression is usually managed in primary care, but most antidepressant trials
are of patients from secondary care mental health services, with eligibility criteria based on …
are of patients from secondary care mental health services, with eligibility criteria based on …
Real-world effect of antidepressants for depressive disorder in primary care: protocol of a population-based cohort study
Introduction Clinical guidelines recommend antidepressants as the first line of treatment for
adults with moderate-to-severe depression. Randomised trials provide the best evidence on …
adults with moderate-to-severe depression. Randomised trials provide the best evidence on …
Management of depression in real-life settings: knowledge gained from large-scale clinical trials
C Thompson - International clinical psychopharmacology, 1994 - journals.lww.com
This paper reports the results of two studies of depressed patients, evaluating the efficacy
and toleration of the selective serotonin reuptake inhibitor (SSRI) sertraline in a general …
and toleration of the selective serotonin reuptake inhibitor (SSRI) sertraline in a general …
Antidepressant treatment for primary care patients with depressive symptoms: Data from the diamond longitudinal cohort study
SK Davidson, H Romaniuk… - Australian & New …, 2020 - journals.sagepub.com
Background: In light of emerging evidence questioning the safety of antidepressants, it is
timely to investigate the appropriateness of antidepressant prescribing. This study estimated …
timely to investigate the appropriateness of antidepressant prescribing. This study estimated …
[HTML][HTML] From the bench to the trench: a comparison of sertraline treatment of major depression in clinical and research patient samples
RB Lydiard, P Perera, E Batzar… - The Primary Care …, 1999 - legacy.psychiatrist.com
Background: New medications that enter the marketplace have been tested almost
exclusively in controlled clinical trials conducted in specialty research settings. There is …
exclusively in controlled clinical trials conducted in specialty research settings. There is …
Severity of depression and response to antidepressants: GENPOD randomised controlled trial
NJ Wiles, J Mulligan, TJ Peters, PJ Cowen… - The British Journal of …, 2012 - cambridge.org
BackgroundAntidepressant prescribing is widespread. Nonetheless, response to
antidepressants is variable. If it was possible to predict response to medication and thus …
antidepressants is variable. If it was possible to predict response to medication and thus …
Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis
B Arroll, W Chin, W Martis… - Journal of primary …, 2016 - CSIRO Publishing
ABSTRACT INTRODUCTION Evidence for the effectiveness of drug treatment for depression
in primary care settings remains limited, with little information on newer antidepressant …
in primary care settings remains limited, with little information on newer antidepressant …